AAAAAA

   
Results: 1-7 |
Results: 7
TARGETED ANTICANCER THERAPY USING RITUXIMAB, A CHIMERIC ANTI-CD20 ANTIBODY (IDEC-C2B8) IN THE TREATMENT OF NON-HODGKINS B-CELL LYMPHOMA
Authors: ANDERSON DR GRILLOLOPEZ A VARNS C CHAMBERS KS HANNA N
Citation: Dr. Anderson et al., TARGETED ANTICANCER THERAPY USING RITUXIMAB, A CHIMERIC ANTI-CD20 ANTIBODY (IDEC-C2B8) IN THE TREATMENT OF NON-HODGKINS B-CELL LYMPHOMA, Biochemical Society transactions, 25(2), 1997, pp. 705-708
ANDO,TADAO - THE COLORS OF LIGHT - HENEGHAN,T
Authors: CHAMBERS KS
Citation: Ks. Chambers, ANDO,TADAO - THE COLORS OF LIGHT - HENEGHAN,T, Graphis, 53(309), 1997, pp. 16-16
KLEIMAN,ALAN
Authors: CHAMBERS KS
Citation: Ks. Chambers, KLEIMAN,ALAN, ART AM, 85(2), 1997, pp. 97-97
CIVERA,VICTORIA
Authors: CHAMBERS KS
Citation: Ks. Chambers, CIVERA,VICTORIA, ART AM, 84(5), 1996, pp. 106-106
CHANG,UCCHIN
Authors: CHAMBERS KS
Citation: Ks. Chambers, CHANG,UCCHIN, ART AM, 83(12), 1995, pp. 103-103
MIN,BYUNGHUN
Authors: CHAMBERS KS
Citation: Ks. Chambers, MIN,BYUNGHUN, ART AM, 83(10), 1995, pp. 137-137
DEPLETION OF B-CELLS IN-VIVO BY A CHIMERIC MOUSE-HUMAN MONOCLONAL-ANTIBODY TO CD20
Authors: REFF ME CARNER K CHAMBERS KS CHINN PC LEONARD JE RAAB R NEWMAN RA HANNA N ANDERSON DR
Citation: Me. Reff et al., DEPLETION OF B-CELLS IN-VIVO BY A CHIMERIC MOUSE-HUMAN MONOCLONAL-ANTIBODY TO CD20, Blood, 83(2), 1994, pp. 435-445
Risultati: 1-7 |